Table of Contents 1 Lenalidomide Market Overview 1.1 Product Overview and Scope of Lenalidomide 1.2 Lenalidomide Segment by Type 1.2.1 Global Lenalidomide Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 5 mg Capsules 1.2.3 10 mg Capsules 1.2.4 15 mg Capsules 1.2.5 25 mg Capsules 1.3 Lenalidomide Segment by Application 1.3.1 Lenalidomide Sales Comparison by Application: 2020 VS 2026 1.3.2 Multiple myeloma (MM) 1.3.3 Myelodysplastic syndromes (MDS) 1.4 Global Lenalidomide Market Size Estimates and Forecasts 1.4.1 Global Lenalidomide Revenue 2015-2026 1.4.2 Global Lenalidomide Sales 2015-2026 1.4.3 Lenalidomide Market Size by Region: 2020 Versus 2026 2 Global Lenalidomide Market Competition by Manufacturers 2.1 Global Lenalidomide Sales Market Share by Manufacturers (2015-2020) 2.2 Global Lenalidomide Revenue Share by Manufacturers (2015-2020) 2.3 Global Lenalidomide Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Lenalidomide Manufacturing Sites, Area Served, Product Type 2.5 Lenalidomide Market Competitive Situation and Trends 2.5.1 Lenalidomide Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Lenalidomide Players (Opinion Leaders) 3 Lenalidomide Retrospective Market Scenario by Region 3.1 Global Lenalidomide Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Lenalidomide Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Lenalidomide Market Facts & Figures by Country 3.3.1 North America Lenalidomide Sales by Country 3.3.2 North America Lenalidomide Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Lenalidomide Market Facts & Figures by Country 3.4.1 Europe Lenalidomide Sales by Country 3.4.2 Europe Lenalidomide Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Lenalidomide Market Facts & Figures by Region 3.5.1 Asia Pacific Lenalidomide Sales by Region 3.5.2 Asia Pacific Lenalidomide Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Lenalidomide Market Facts & Figures by Country 3.6.1 Latin America Lenalidomide Sales by Country 3.6.2 Latin America Lenalidomide Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Lenalidomide Market Facts & Figures by Country 3.7.1 Middle East and Africa Lenalidomide Sales by Country 3.7.2 Middle East and Africa Lenalidomide Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Lenalidomide Historic Market Analysis by Type 4.1 Global Lenalidomide Sales Market Share by Type (2015-2020) 4.2 Global Lenalidomide Revenue Market Share by Type (2015-2020) 4.3 Global Lenalidomide Price Market Share by Type (2015-2020) 4.4 Global Lenalidomide Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Lenalidomide Historic Market Analysis by Application 5.1 Global Lenalidomide Sales Market Share by Application (2015-2020) 5.2 Global Lenalidomide Revenue Market Share by Application (2015-2020) 5.3 Global Lenalidomide Price by Application (2015-2020) 6 Company Profiles and Key Figures in Lenalidomide Business 6.1 Celgene 6.1.1 Corporation Information 6.1.2 Celgene Description, Business Overview and Total Revenue 6.1.3 Celgene Lenalidomide Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Celgene Products Offered 6.1.5 Celgene Recent Development 6.2 Exova 6.2.1 Exova Lenalidomide Production Sites and Area Served 6.2.2 Exova Description, Business Overview and Total Revenue 6.2.3 Exova Lenalidomide Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Exova Products Offered 6.2.5 Exova Recent Development 7 Lenalidomide Manufacturing Cost Analysis 7.1 Lenalidomide Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Lenalidomide 7.4 Lenalidomide Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Lenalidomide Distributors List 8.3 Lenalidomide Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Lenalidomide Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Lenalidomide by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Lenalidomide by Type (2021-2026) 10.2 Lenalidomide Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Lenalidomide by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Lenalidomide by Application (2021-2026) 10.3 Lenalidomide Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Lenalidomide by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Lenalidomide by Region (2021-2026) 10.4 North America Lenalidomide Estimates and Projections (2021-2026) 10.5 Europe Lenalidomide Estimates and Projections (2021-2026) 10.6 Asia Pacific Lenalidomide Estimates and Projections (2021-2026) 10.7 Latin America Lenalidomide Estimates and Projections (2021-2026) 10.8 Middle East and Africa Lenalidomide Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Lenalidomide Sales (K Pcs) Growth Rate Comparison by Type (2015-2026) Table 2. Global Lenalidomide Sales (K Pcs) Comparison by Application: 2020 VS 2026 Table 3. Global Lenalidomide Market Size by Type (K Pcs) (US$ Million) (2020 VS 2026) Table 4. Global Key Lenalidomide Manufacturers Covered in This Study Table 5. Global Lenalidomide Sales (K Pcs) by Manufacturers (2015-2020) Table 6. Global Lenalidomide Sales Share by Manufacturers (2015-2020) Table 7. Global Lenalidomide Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Lenalidomide Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Lenalidomide Average Price (USD/Pcs) of Key Manufacturers (2015-2020) Table 10. Manufacturers Lenalidomide Sales Sites and Area Served Table 11. Manufacturers Lenalidomide Product Types Table 12. Global Lenalidomide Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Lenalidomide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lenalidomide as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Lenalidomide Players Table 16. Global Lenalidomide Sales (K Pcs) by Region (2015-2020) Table 17. Global Lenalidomide Sales Market Share by Region (2015-2020) Table 18. Global Lenalidomide Revenue (Million US$) by Region (2015-2020) Table 19. Global Lenalidomide Revenue Market Share by Region (2015-2020) Table 20. North America Lenalidomide Sales by Country (2015-2020) (K Pcs) Table 21. North America Lenalidomide Sales Market Share by Country (2015-2020) Table 22. North America Lenalidomide Revenue by Country (2015-2020) (US$ Million) Table 23. North America Lenalidomide Revenue Market Share by Country (2015-2020) Table 24. Europe Lenalidomide Sales by Country (2015-2020) (K Pcs) Table 25. Europe Lenalidomide Sales Market Share by Country (2015-2020) Table 26. Europe Lenalidomide Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Lenalidomide Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Lenalidomide Sales by Region (2015-2020) (K Pcs) Table 29. Asia Pacific Lenalidomide Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Lenalidomide Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Lenalidomide Revenue Market Share by Region (2015-2020) Table 32. Latin America Lenalidomide Sales by Country (2015-2020) (K Pcs) Table 33. Latin America Lenalidomide Sales Market Share by Country (2015-2020) Table 34. Latin America Lenalidomide Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Lenalidomide Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Lenalidomide Sales by Country (2015-2020) (K Pcs) Table 37. Middle East and Africa Lenalidomide Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Lenalidomide Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Lenalidomide Revenue Market Share by Country (2015-2020) Table 40. Global Lenalidomide Sales (K Pcs) by Type (2015-2020) Table 41. Global Lenalidomide Sales Share by Type (2015-2020) Table 42. Global Lenalidomide Revenue (Million US$) by Type (2015-2020) Table 43. Global Lenalidomide Revenue Share by Type (2015-2020) Table 44. Global Lenalidomide Price (USD/Pcs) by Type (2015-2020) Table 45. Global Lenalidomide Sales (K Pcs) by Application (2015-2020) Table 46. Global Lenalidomide Sales Market Share by Application (2015-2020) Table 47. Global Lenalidomide Sales Growth Rate by Application (2015-2020) Table 48. Celgene Lenalidomide Corporation Information Table 49. Celgene Description and Business Overview Table 50. Celgene Lenalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 51. Celgene Main Product Table 52. Celgene Recent Development Table 53. Exova Lenalidomide Corporation Information Table 54. Exova Corporation Information Table 55. Exova Lenalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 56. Exova Main Product Table 57. Exova Recent Development Table 58. Sales Base and Market Concentration Rate of Raw Material Table 59. Key Suppliers of Raw Materials Table 60. Lenalidomide Distributors List Table 61. Lenalidomide Customers List Table 62. Market Key Trends Table 63. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 64. Key Challenges Table 65. Global Lenalidomide Sales (K Pcs) Forecast by Type (2021-2026) Table 66. Global Lenalidomide Sales Market Share Forecast by Type (2021-2026) Table 67. Global Lenalidomide Revenue (Million US$) Forecast by Type (2021-2026) Table 68. Global Lenalidomide Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 69. Global Lenalidomide Sales (K Pcs) Forecast by Application (2021-2026) Table 70. Global Lenalidomide Revenue (Million US$) Forecast by Application (2021-2026) Table 71. Global Lenalidomide Sales (K Pcs) Forecast by Region (2021-2026) Table 72. Global Lenalidomide Sales Market Share Forecast by Region (2021-2026) Table 73. Global Lenalidomide Revenue Forecast by Region (2021-2026) (US$ Million) Table 74. Global Lenalidomide Revenue Market Share Forecast by Region (2021-2026) Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Lenalidomide Figure 2. Global Lenalidomide Sales Market Share by Type: 2020 VS 2026 Figure 3. 5 mg Capsules Product Picture Figure 4. 10 mg Capsules Product Picture Figure 5. 15 mg Capsules Product Picture Figure 6. 25 mg Capsules Product Picture Figure 7. Global Lenalidomide Consumption Market Share by Application: 2020 VS 2026 Figure 8. Multiple myeloma (MM) Figure 9. Myelodysplastic syndromes (MDS) Figure 10. Global Lenalidomide Market Size 2015-2026 (US$ Million) Figure 11. Global Lenalidomide Sales Capacity (K Pcs) (2015-2026) Figure 12. Global Lenalidomide Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Lenalidomide Sales Share by Manufacturers in 2020 Figure 14. Global Lenalidomide Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Lenalidomide Revenue in 2019 Figure 16. Lenalidomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Lenalidomide Sales Market Share by Region (2015-2020) Figure 18. Global Lenalidomide Sales Market Share by Region in 2019 Figure 19. Global Lenalidomide Revenue Market Share by Region (2015-2020) Figure 20. Global Lenalidomide Revenue Market Share by Region in 2019 Figure 21. North America Lenalidomide Sales Market Share by Country in 2019 Figure 22. North America Lenalidomide Revenue Market Share by Country in 2019 Figure 23. U.S. Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 24. U.S. Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 26. Canada Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Lenalidomide Sales Market Share by Country in 2019 Figure 28. Europe Lenalidomide Revenue Market Share by Country in 2019 Figure 29. Germany Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 30. Germany Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 32. France Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 34. U.K. Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 36. Italy Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 38. Russia Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Lenalidomide Sales Market Share by Region in 2019 Figure 40. Asia Pacific Lenalidomide Revenue Market Share by Region in 2019 Figure 41. China Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 42. China Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 44. Japan Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 46. South Korea Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 48. India Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 50. Australia Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 52. Taiwan Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 54. Indonesia Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 56. Thailand Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 58. Malaysia Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 60. Philippines Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 62. Vietnam Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Lenalidomide Sales Market Share by Country in 2019 Figure 64. Latin America Lenalidomide Revenue Market Share by Country in 2019 Figure 65. Mexico Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 66. Mexico Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 68. Brazil Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 70. Argentina Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Lenalidomide Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Lenalidomide Revenue Market Share by Country in 2019 Figure 73. Turkey Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 74. Turkey Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 76. Saudi Arabia Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E Lenalidomide Sales Growth Rate (2015-2020) (K Pcs) Figure 78. U.A.E Lenalidomide Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Lenalidomide by Type (2015-2020) Figure 80. Sales Market Share of Lenalidomide by Type in 2019 Figure 81. Revenue Share of Lenalidomide by Type (2015-2020) Figure 82. Revenue Market Share of Lenalidomide by Type in 2019 Figure 83. Global Lenalidomide Sales Growth by Type (2015-2020) (K Pcs) Figure 84. Global Lenalidomide Sales Market Share by Application (2015-2020) Figure 85. Global Lenalidomide Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Lenalidomide by Application (2015-2020) Figure 87. Global Revenue Share of Lenalidomide by Application in 2020 Figure 88. Celgene Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Exova Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Price Trend of Key Raw Materials Figure 91. Manufacturing Cost Structure of Lenalidomide Figure 92. Manufacturing Process Analysis of Lenalidomide Figure 93. Lenalidomide Industrial Chain Analysis Figure 94. Channels of Distribution Figure 95. Distributors Profiles Figure 96. Porter's Five Forces Analysis Figure 97. North America Lenalidomide Sales (K Pcs) and Growth Rate Forecast (2021-2026) Figure 98. North America Lenalidomide Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 99. Europe Lenalidomide Sales (K Pcs) and Growth Rate Forecast (2021-2026) Figure 100. Europe Lenalidomide Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 101. Latin America Lenalidomide Sales (K Pcs) and Growth Rate Forecast (2021-2026) Figure 102. Latin America Lenalidomide Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 103. Middle East and Africa Lenalidomide Sales (K Pcs) and Growth Rate Forecast (2021-2026) Figure 104. Middle East and Africa Lenalidomide Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 105. Asia Pacific Lenalidomide Sales (K Pcs) and Growth Rate Forecast (2021-2026) Figure 106. Asia Pacific Lenalidomide Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 107. Bottom-up and Top-down Approaches for This Report Figure 108. Data Triangulation Figure 109. Key Executives Interviewed

Celgene Exova